Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial.
about
Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of AntiretroviralsGuidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive IndividualsEfavirenz and the CNS: what we already know and questions that need to be answeredPharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous Meningitis.CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.
P2860
Q28069383-2356F503-7D3D-4F71-AD30-E26FB6B012BBQ28073408-F663A6A8-2DC3-428E-8938-DD23690D589EQ28085028-D413517B-E768-4B49-A749-CFA97F9F2398Q36554279-EE75E5E8-A4D1-400E-80C8-30F3DC64A5E2Q39304616-56FD5A74-25BD-4628-8CA7-3129CAFDB387Q40129359-1CD6BCAF-5146-46F0-85D4-992C30E5C5C6Q40531475-F389A5C3-4A31-4738-9885-0EF9BCB3CC92
P2860
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cerebrospinal fluid exposure o ...... a randomized controlled trial.
@en
type
label
Cerebrospinal fluid exposure o ...... a randomized controlled trial.
@en
prefLabel
Cerebrospinal fluid exposure o ...... a randomized controlled trial.
@en
P2093
P2860
P50
P356
P1476
Cerebrospinal fluid exposure o ...... a randomized controlled trial.
@en
P2093
Alan Winston
Alieu Amara
Amanda Clarke
Anchalee Avihingsanon
David A Cooper
ENCORE Cerebrospinal Fluid (CSF) Substudy Team
ENCORE Cerebrospinal Fluid CSF Substudy Team
Heiko Jessen
Laura Else
Rebekah Puls
P2860
P304
P356
10.1093/CID/CIU976
P407
P577
2014-12-11T00:00:00Z